Division of Infectious Diseases & Environmental Medicine
Leadership
Name:
John Zurlo, MD
Position:
Director, Division of Infectious Diseases
Email:
John.Zurlo@jefferson.edu
Contact
Name:
Division of Infectious Disease & Environmental Medicine
1101 Market Street
Suite 2720
Philadelphia, PA 19107
Contact Number(s):
- 215-955-7785
- 215-955-9362 (fax)
Research Activities
Publications
- Identifying barriers and facilitators to audit & feedback in general practice in Italy: a qualitative study
- Supporting Evidence-based Responses to Emotional Needs in Emphysema (SERENE): protocol for a randomized, open-label mechanistic trial comparing Coping Skills Training and disease-specific education for depressive symptoms conducted in United States health systems
- Modes of cannabis administration, cannabis and tobacco co-use, and associations with respiratory and cannabis use outcomes in a permissive medical cannabis state
- Peritraumatic C-reactive protein levels predict pain outcomes following traumatic stress exposure in a sex-dependent manner
- Infectious Disease Screening and Vaccinations Guidelines for Patients Initiating Immunosuppression for Dermatologic Conditions: A Multidisciplinary Design and Quality Improvement Initiative
- Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivors
- Exposure and impact: highlights from the second scientific conference and recent activities of the International Society of Radiation Epidemiology and Dosimetry (ISoRED)
- Inflammatory markers in the emergency department and PTSD symptoms in the AURORA Study: A longitudinal cohort study
- Multi-Level Variable Selection Using a BART-Enhanced Mixed-Effects Framework
- Safety and efficacy of individualised exercise and NAD+precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial
- Celiac plexus radiosurgery for retroperitoneal pain in advanced cancer: a pre-specified secondary analysis of health-related quality of life in a phase II single-arm trial
- Out-of-Pocket Costs and Antihypertensive Medication Use Among Veterans: A Natural Experiment
- Influence of Neighborhood Disadvantage on All-Cause Mortality Following Moderate-to-Severe Traumatic Brain Injury: A TBI Model Systems Cohort Study
- Primary Care Use and Clinical Outcomes in a Prevalent Cohort of Patients Receiving Hemodialysis
- Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort
- Non-injectable versus injectable epinephrine treatment thresholds for acute allergic reactions in the community
- Acute Care Use Among People With Sickle Cell Disease, Sickle Cell Data Collection Program, 8 US States, 2018
- Emotion Identification and Emotion Sensitivity Following Interpersonal and Noninterpersonal Traumatic Experiences: Results From the AURORA Study
- Author Correction: Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study (Nature Medicine, (2026), 32, 1, (197-223), 10.1038/s41591-025-04077-9)
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023